Abstract
Objectives: In late March 2020, Texas issued an executive order that was interpreted to prohibit most abortions. We compared Texas residents’ patterns of out-of-state travel before and during the order.
Highlights
To understand if patient safety differs by physician specialty, we compared major and any abortion-related morbidity and adverse events in abortion care provided by physicians of other specialties versus obstetrician-gynecologist physicians (Ob-Gyn)
The study cohort included 34,633 patients who had 35,272 abortions; 4,708 (13.3%) abortions provided by physicians of other specialties and 30,564 (86.7%) abortions provided by Ob-Gyns
There was no statistically significant difference in major abortion-related morbidity or adverse events comparing physicians of other specialties versus Ob-Gyns (adjusted OR 0.98,), and no statistically significant difference in any abortion-related morbidity or adverse events comparing physicians of other specialties versus Ob-Gyn (adjusted OR 0.92,)
Summary
Compare induction to delivery intervals and complications in second trimester labor induction using mifepristone with misoprostol vs misoprostol alone. Methods: A retrospective analysis was performed of second trimester induction terminations at two urban medical centers over ten years. Inclusion criteria were pregnancies between 14.0 weeks and 23.6 weeks gestation without evidence of labor, intrauterine infection, or ruptured membranes upon admission. Comparisons between mifepristone plus misoprostol or misoprostol alone were performed, including composite complications (retained placenta requiring surgery, infection, hemorrhage, blood transfusion, failed induction, ICU admission, and readmission), total misoprostol dosage, and induction to delivery intervals. Results: The final analysis included 406 patients, 286 (66%) at gestational age > 20 weeks. Most were for fetal anomalies (196, 48.3%) or intrauterine fetal demise (199, 49.0%). Thirty-two percent (n=133) received mifepristone plus misoprostol and sixty-seven percent (n= 273) received misoprostol alone
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callSimilar Papers
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
